Intrinsic Value of S&P & Nasdaq Contact Us

Third Harmonic Bio, Inc. THRD

NASDAQ Global Market

SharesGrow Score
68/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.15
+200.2%

Third Harmonic Bio, Inc. (THRD) current share price is $5.38. The gold spot price is $4,808.10 per troy ounce. Using the formula: THRD in gold = $5.38 × 31.1035 ÷ $4,808.10 = 0.0348 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of THRD when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding THRD shares over the measured period.

THRD in US Dollars
Gold in US Dollars
THRD in Gold (grams per share)

Real Wealth Growth Rate

THRD
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{THRD}_{\text{gold}}(t) = \frac{P_{\text{THRD}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{THRD}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{THRD}_{\text{gold}}^{(T)}}{\text{THRD}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{THRD}_\text{gold}^{(0)}$ = initial gold-price, $\text{THRD}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
CGEM
CGEM
Cullinan Oncology, Inc.
$14.35
+0.70%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
MACK
MACK
Merrimack Pharmaceuticals, Inc.
$15.15
+0.10%
GRPH
GRPH
Graphite Bio, Inc.
$3.18
-2.75%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message